Andrew J. Muir
Elite in Hepatitis C
Check Dr. Andrew J. Muir's experience treating your condition:
About Dr. Andrew J. Muir

Andrew Muir is a Gastroenterologist in Durham, North Carolina. Muir has been practicing medicine for over 30 years and is rated as an Elite expert by MediFind in the treatment of Hepatitis C. He is also highly rated in 26 other conditions, according to our data. His top areas of expertise are Hepatitis C, Hepatitis, Sclerosing Cholangitis, Cholangitis, and Liver Transplant. He is licensed to treat patients in North Carolina. Muir is currently accepting new patients.

His clinical research consists of co-authoring 198 peer reviewed articles and participating in 21 clinical trials in the past 15 years. In particular, he has co-authored 117 articles and participated in 9 clinical trials in the study of Hepatitis C.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Andrew J. Muir it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
30 Duke Medicine Cir, Durham, NC 27710
Other Locations
10207 Cerny St, Raleigh, NC 27617
Background & Education
Graduate Institution
Duke University School Of Medicine, 1993
Internal Medicine in NC
Hospital Affiliations
Duke Regional Hospital
Duke University Hospital
Duke Raleigh Hospital
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

20 Clinical Trials

A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041 Administered Subcutaneously to Patients With Type 1 Diabetes Mellitus
A Randomized, Placebo-controlled Pilot Study of Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis (PSC)
TrialNet Pathway to Prevention of T1D
The Insulin-Only Bionic Pancreas Pivotal Trial: Testing the iLet in Adults and Children With Type 1 Diabetes
Hydroxychloroquine for Prevention of Abnormal Glucose Tolerance and Diabetes in Individuals At-risk for Type 1 Diabetes Mellitus (T1D)
Exploring Immunologic Effects of Oral Insulin in Relatives at Risk for Type 1
Quality of Life in Primary Sclerosing Cholangitis
COPE-HCV: Continuous Interferon Delivery Via the Medtronic Paradigm Pump Infusion System Clinical Evaluation for Chronic HCV
Evaluation of Wirelessly Observed Therapy to Optimize Adherence in Patients With Hepatitis C and Increased Risk for Nonadherence to Treatment
Hepatitis C Alcohol Reduction Treatment - Randomized Controlled Trial (Hep ART-RCT)
View 15 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors